Literature DB >> 7238251

Cimetidine-induced hepatitis. Electron microscopic observations and clinical pattern of liver injury.

I Lorenzini, A M Jezequel, F Orlandi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7238251     DOI： 10.1007/bf01391643

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  8 in total

1.  [Cholestatic hepatosis under Cimetidine].

Authors:  H Züchner
Journal:  Dtsch Med Wochenschr       Date:  1977-12-02       Impact factor: 0.628

2.  Cimetidine inhibits microsomal drug metabolism in the rat.

Authors:  J Puurunen; O Pelkonen
Journal:  Eur J Pharmacol       Date:  1979-05-01       Impact factor: 4.432

3.  Safety of cimetidine.

Authors:  D M Kruss; A Littman
Journal:  Gastroenterology       Date:  1978-02       Impact factor: 22.682

4.  Cimetidine cholestatic jaundice in children.

Authors:  J R Lilly; D C Hitch; N B Javitt
Journal:  J Surg Res       Date:  1978-05       Impact factor: 2.192

5.  Changes in plasma -glutamyl transpeptidase activity associated with alterations in drug metabolism in man.

Authors:  J B Whitfield; D W Moss; G Neale; M Orme; A Breckenridge
Journal:  Br Med J       Date:  1973-02-10

6.  Cimetidine hepatitis.

Authors:  J P Villeneuve; H A Warner
Journal:  Gastroenterology       Date:  1979-07       Impact factor: 22.682

7.  Cimetidine: interaction with oral anticoagulants in man.

Authors:  M J Serlin; R G Sibeon; S Mossman; A M Breckenridge; J R Williams; J L Atwood; J M Willoughby
Journal:  Lancet       Date:  1979-08-18       Impact factor: 79.321

8.  Evaluation of fluorimetrically estimated serum bile acid in liver disease.

Authors:  T Osuga; K Mitamura; F Mashige; D Imai
Journal:  Clin Chim Acta       Date:  1977-02-15       Impact factor: 3.786
  8 in total
  9 in total

1.  Chronic active hepatitis associated with cimetidine.

Authors:  P T Boyd; F Lepre; J D Dickey
Journal:  BMJ       Date:  1989-02-04

2.  T3/T4 ratio in cimetidine treatment.

Authors:  S Itoh; M Nakajima; Y Yamaba; S Matsuo
Journal:  Dig Dis Sci       Date:  1986-11       Impact factor: 3.199

Review 3.  Safety of acid-suppressing drugs.

Authors:  R A Smallwood; R G Berlin; N Castagnoli; H P Festen; C J Hawkey; S K Lam; M J Langman; P Lundborg; A Parkinson
Journal:  Dig Dis Sci       Date:  1995-02       Impact factor: 3.199

Review 4.  Nephrotoxicity and hepatotoxicity of histamine H2 receptor antagonists.

Authors:  A A Fisher; D G Le Couteur
Journal:  Drug Saf       Date:  2001-01       Impact factor: 5.606

Review 5.  Drug-induced cholestasis.

Authors:  H J Zimmerman; J H Lewis
Journal:  Med Toxicol       Date:  1987 Mar-Apr

6.  Cimetidine disposition in patients with Laennec's cirrhosis during multiple dosing therapy.

Authors:  J P Cello; S Oie
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

7.  Effect of cimetidine on portal pressure and systemic hemodynamics in patients with and without liver cirrhosis.

Authors:  N Nagasue; Y Ogawa; H Yukaya; M Okita; M Yamamoto; T Higashi
Journal:  Gastroenterol Jpn       Date:  1985-04

Review 8.  Drug effects on the liver. An updated tabular compilation of drugs and drug-related hepatic diseases.

Authors:  J Ludwig; R Axelsen
Journal:  Dig Dis Sci       Date:  1983-07       Impact factor: 3.199

Review 9.  Adverse reactions and interactions with H2-receptor antagonists.

Authors:  J Penston; K G Wormsley
Journal:  Med Toxicol       Date:  1986 May-Jun
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.